Share on StockTwits

Perrigo Company PLC (NASDAQ:PRGO) has earned an average rating of “Buy” from the fourteen ratings firms that are currently covering the stock, American Banking & Market News reports. Three equities research analysts have rated the stock with a hold recommendation, seven have given a buy recommendation and one has given a strong buy recommendation to the company. The average twelve-month target price among brokerages that have covered the stock in the last year is $166.25.

Perrigo Company PLC (NASDAQ:PRGO) opened at 143.28 on Wednesday. Perrigo Company PLC has a 52-week low of $115.94 and a 52-week high of $168.39. The stock has a 50-day moving average of $150.0 and a 200-day moving average of $149.3. The company has a market cap of $19.171 billion and a price-to-earnings ratio of 77.69.

A number of analysts have recently weighed in on PRGO shares. Analysts at Deutsche Bank initiated coverage on shares of Perrigo Company PLC in a research note on Tuesday, July 22nd. They set a “buy” rating and a $189.00 price target on the stock. Separately, analysts at Morgan Stanley downgraded shares of Perrigo Company PLC from an “overweight” rating to an “equal weight” rating in a research note on Friday, July 11th. Finally, analysts at Argus cut their price target on shares of Perrigo Company PLC from $175.00 to $160.00 in a research note on Thursday, May 15th. They now have a “buy” rating on the stock.

Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (NASDAQ:PRGO) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri.

Receive News & Ratings for Perrigo Company PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo Company PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.